ID
MDT icon

Integral Derivatives’s Medtronic MDT Stock Holding History

Integral Derivatives’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,616
Closed -$530K – 1228
2017
Q3 		$515K Hold
6,616
– – 0.01% 722
2017
Q2 		$587K Sell
6,616
-8,311
-56% -$701K 0.01% 660
2017
Q1 		$1.2M Sell
14,927
-12,706
-46% -$993K 0.02% 464
2016
Q4 		$1.97M Buy
27,633
+9,975
+56% +$784K 0.04% 329
2016
Q3 		$1.53M Buy
+17,658
New +$1.54M 0.03% 332
2015
Q4 		– Sell
-5,158
Closed -$388K – 1157
2015
Q3 		$345K Buy
+5,158
New +$380K 0.01% 814
2015
Q1 		– Sell
-2,918
Closed -$221K – 1282
2014
Q4 		$211K Sell
2,918
-10,500
-78% -$729K ﹤0.01% 1218
2014
Q3 		$831K Buy
+13,418
New +$853K 0.01% 788

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Integral Derivatives's MDT Position: Q4 2017 in Review

Integral Derivatives sold out of Medtronic (MDT) in Q4 2017, closing a stake of 6,616 shares — an estimated $530K sold.

Integral Derivatives first reported a position in MDT in Q3 2014 and held it in 8 quarters. The position peaked at $1.97M in Q4 2016. 1,409 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Integral Derivatives reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 6,616 Medtronic shares in Q4 2017, an estimated $530K.
  • Integral Derivatives first reported a position in Medtronic in Q3 2014 and held it in 8 quarters.
  • Integral Derivatives's Medtronic position peaked at $1.97M in Q4 2016.
  • 1,409 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.